These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8356062)

  • 1. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.
    Briner TJ; Kuo MC; Keating KM; Rogers BL; Greenstein JL
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7608-12. PubMed ID: 8356062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects.
    Mark PG; Segal DB; Dallaire ML; Garman RD
    Clin Exp Allergy; 1996 Nov; 26(11):1316-28. PubMed ID: 8955581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen.
    Reefer AJ; Carneiro RM; Custis NJ; Platts-Mills TA; Sung SS; Hammer J; Woodfolk JA
    J Immunol; 2004 Mar; 172(5):2763-72. PubMed ID: 14978075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1.
    Haselden BM; Syrigou E; Jones M; Huston D; Ichikawa K; Chapman MD; Kay AB; Larché M
    J Allergy Clin Immunol; 2001 Sep; 108(3):349-56. PubMed ID: 11544452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peptide therapy on ex vivo T-cell responses.
    Marcotte GV; Braun CM; Norman PS; Nicodemus CF; Kagey-Sobotka A; Lichtenstein LM; Essayan DM
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):506-13. PubMed ID: 9564804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.
    Pène J; Desroches A; Paradis L; Lebel B; Farce M; Nicodemus CF; Yssel H; Bousquet J
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):571-8. PubMed ID: 9802364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.
    Counsell CM; Bond JF; Ohman JL; Greenstein JL; Garman RD
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):884-94. PubMed ID: 8939151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.
    Renand A; Archila LD; McGinty J; Wambre E; Robinson D; Hales BJ; Thomas WR; Kwok WW
    J Allergy Clin Immunol; 2015 Dec; 136(6):1627-1635.e13. PubMed ID: 26371841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes.
    Rogers BL; Bond JF; Craig SJ; Nault AK; Segal DB; Morgenstern JP; Chen MS; Bizinkauskas CB; Counsell CM; Lussier AM
    Mol Immunol; 1994 Sep; 31(13):955-66. PubMed ID: 7521933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects.
    Simons FE; Imada M; Li Y; Watson WT; HayGlass KT
    Int Immunol; 1996 Dec; 8(12):1937-45. PubMed ID: 8982778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Fel d.I: Expression, purification, IgE binding and reaction with cat-allergic human T cells.
    Rogers BL; Morgenstern JP; Garman RD; Bond JF; Kuo MC
    Mol Immunol; 1993 Apr; 30(6):559-68. PubMed ID: 8487777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness.
    Oshiba A; Hamelmann E; Bradley KL; Loader JE; Renz H; Larsen GL; Gelfand EW
    Am J Respir Crit Care Med; 1996 Jan; 153(1):102-9. PubMed ID: 8542101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice.
    Hoyne GF; O'Hehir RE; Wraith DC; Thomas WR; Lamb JR
    J Exp Med; 1993 Nov; 178(5):1783-8. PubMed ID: 8228823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cat dander-specific T lymphocytes from atopic patients.
    van Neerven RJ; van de Pol MM; van Milligen FJ; Jansen HM; Aalberse RC; Kapsenberg ML
    J Immunol; 1994 Apr; 152(8):4203-10. PubMed ID: 8144980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific T cell tolerance down-regulates mast cell responses in vivo.
    Treter S; Luqman M
    Cell Immunol; 2000 Dec; 206(2):116-24. PubMed ID: 11161443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects.
    Oldfield WL; Kay AB; Larché M
    J Immunol; 2001 Aug; 167(3):1734-9. PubMed ID: 11466398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of endotoxin on the production of IgE, IgG1 and IgG2a antibodies against the cat allergen Fel d 1 in mice.
    Ormstad H; Groeng EC; Duffort O; Løvik M
    Toxicology; 2003 Jun; 188(2-3):309-18. PubMed ID: 12767700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy.
    Martínez-Gómez JM; Johansen P; Rose H; Steiner M; Senti G; Rhyner C; Crameri R; Kündig TM
    Allergy; 2009 Jan; 64(1):172-8. PubMed ID: 19076537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.